GE HealthCare Technology (NASDAQ: GEHC) stock added $2.56 to its trading prices on June 30 trading session; it opened trading at $79.42, lowering to $79.31 and hitting a high of $81.41; it closed trading at $81.24 with intraday trading volume of 3.43 Million.
In the past week, GEHC stock reflected an impressive hike of more than 1.50%, and the price moved upwards by 3.44% in the past month. Per technical indicators and analyst ratings, the ongoing movement is a good time to buy GEHC stocks.
The 52- weeks price target of GEHC stock is $89.25, around 9.86% higher than the current trading price. In the past 52 weeks stock highest traded at $87.83, and the lowest trading price was $53.00.
The average trading volume of GEHC stock is 3.43 Million, and the company’s market capitalization is 3.556 Million. In the last two trading sessions of 29 and 30 June, GE HealthCare Technology reflected the majority of buyers compared to sellers.
The company’s revenue to a profit conversion constitutes 39% gross profit, 17% EBITDA, 14% EBIT and 10% EBT. Over 390 Million of GE HealthCare Technology shares are free-floating, and financial backers of the company and the board members closely hold the remaining 62.775 Million shares.
In Q1 2023, GE HealthCare Technology reported 1.58% more revenue than estimated revenue; it was assumed that the company might report $4.63 Billion in revenue, but surprisingly its investors’ company reported $4.71 Billion in revenue.
As per estimation, GE HealthCare Technology might report $4.79 Billion in Q2 and $4.78 Billion in Q3. In Q1 2023 Earning Per Share of the company surged more than 7.10% than the estimated EPS.
Most of the company’s revenue is generated from Ultrasound, Patient Care Solutions, Pharmaceutical Diagnostics, Healthcare Financial, and Imaging. GE HealthCare Technology primarily serves patients in the United States, China, and several other regions over the globe.
The company’s short-term assets are $7.82 Billion, and liabilities are $7.19 Billion. Moreover, in the long term total assets of the company are $19.72 Billion and $10.76 Billion. From the total generated revenue of Q1 2023, the company’s net income was $372.00 Million with a profit margin of 7.90%.
In the financial year 2022, GE HealthCare Technology generated $3.42 Billion from ultrasound, $2.92 Billion from patient care solutions, $1.96 Billion from pharmaceutical diagnostics, $60.00 Million from Healthcare Financial, and $9.98 Billion from Imaging.
Around $7.82 Billion in revenue from the United States, $2.33 Billion from China, and the remaining $8.20 Billion from other regions of the globe.
Disclaimer
The views and opinions stated by the author, or any people named in this article, are for informational ideas only and do not establish financial, investment, or other advice. Investing in or trading crypto assets comes with a risk of financial loss.
Andrew is a blockchain developer who developed his interest in cryptocurrencies while his post-graduation. He is a keen observer of details and shares his passion for writing along with being a developer. His backend knowledge about blockchain helps him give a unique perspective to his writing
Source: https://www.thecoinrepublic.com/2023/07/02/gehc-stock-price-rose-2-50-intraday-reflecting-major-buyers/